Latest filing published 03 Mar 2023 for Opiant Pharmaceuticals, INC., €37k. Read the official filing
No signal scores available.
This profile gathers the share dealings of Masuoka K. Lorianne in Opiant Pharmaceuticals, Inc., where the filings describe the role as board member. Between 15 June 2021 and 2 March 2023, the trades on record add up to 3 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 3 March 2023, reports a transaction of €37k in Opiant Pharmaceuticals, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations